Phase 1 Study of Intravaginal KB15A (NCT07222020)
Phase I, Placebo-Controlled, Double-Blinded, Randomized, Interventional, Safety and Pharmacokinetic Study of Single and Multiple Dosing of KB15A, a Vaginal Film Containing KB15A, an Anti-Sperm Monoclonal Antibody
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to determine the safety and mucosal pharmacokinetics of KB15A, a vaginal film containing an anti-sperm monoclonal antibody, in healthy adult women. Researchers will compare KB15A use to placebo use, primarily to see if KB15A is associated with adverse events, and also to understand the local and systemic distribution of the KB15A monoclonal antibody following use of the vaginal film. Participants will be assessed for the genital, mucosal and systemic safety and pharmacokinetics of KB15A in a preliminary single-dose phase of the study, where they will receive two single doses of either KB15A or placebo vaginal film, and again in a multiple-dose phase of the study, where they will receive 14 daily doses of either KB15A or placebo vaginal film.
Who can join: Review the eligibility criteria below.
Location: Virginia Health Sciences at Old Dominion University — Norfolk, Virginia
Age range: 18 Years to 45 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Virginia Health Sciences at Old Dominion University — Norfolk, Virginia
📞 Contact the Study Coordinator
Phone: (757) 446-0529
Email: ayerskl@odu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Healthy Subjects
- Metabolic Responses to Spermidine Supplementation. — Addison, Illinois
- Lysine-specific Demethylase 1 and Salt-sensitivity in Humans — Boston, Massachusetts
- Effect of Stimulation on the Vagus Nerve — Indianapolis, Indiana
- Training Effects on Fuel Metabolism — Minneapolis, Minnesota
- Methemoglobin Concentration in High Dose Inhaled Nitric Oxide — Boston, Massachusetts
- Effect of Proton Pump Inhibitors on Gut Microbiota Composition and Metabolites in Healthy Subjects Using CapScan — Mountain View, California
Explore by condition: All Healthy Subjects clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.